Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699696 · ClinicalTrials.gov registry record
A Pilot Analysis of the Association Between Anesthesia Induction Dosing and AKI in the Elderly Population
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 541
- Enrollment target
NCT03699696: Completed study, sponsored by Yale University.
NCT03699696 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 541 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03699696 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
Study Summary
This study proposes to perform a pilot observational study looking at the doses of propofol used for the induction of general anesthesia and its association with the development of hypotension and AKI among elderly patients at YNHH.
Primary Outcome
Percentage of patients \>=65 who received greater than the FDA approved induction dosage of propofol
Interventions
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2018-07-08 |
What the finished NCT03699696 record still lists
NCT03699696 is an observational study that tracks outcomes without assigning an intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Propofol is the first listed.
NCT03699696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03699696 about?
NCT03699696 is a clinical study titled "A Pilot Analysis of the Association Between Anesthesia Induction Dosing and AKI in the Elderly Population". This study proposes to perform a pilot observational study looking at the doses of propofol used for the induction of general anesthesia and its association with the development of hypotension and AKI among elderly patients at YNHH.
What is the current status of trial NCT03699696?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2014-12-01. Estimated completion is 2018-07-08.
What interventions are being tested in trial NCT03699696?
The interventions under investigation include: Propofol (DRUG).
Who is sponsoring clinical trial NCT03699696?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI